Articles tagged with Mumps
A cohort study found that most children received their first dose of MMR vaccine on time, but the proportion not receiving it by age 2 has increased. Children who missed early vaccinations were more likely to not receive any MMR vaccine by age 2.
A new survey by the Annenberg Public Policy Center finds a small but significant drop in the proportion of the public that would recommend getting the MMR vaccine, citing concerns over its safety and effectiveness. The survey also shows declines in perceived safety and effectiveness for other vaccines, such as seasonal flu and Covid-19.
Public Health Alerts provide concise, data-driven information on disease outbreaks and urgent health events. The new series, launched by NEJM Evidence and CIDRAP, offers expert-reviewed reports to support public health evidence-based care.
A Dutch study found that vaccination coverage among children declined faster in households with lower income and those not attending daycare. The study, which analyzed over 2 million children, identified sociodemographic factors contributing to the decline, including parental education and migration background.
A large-scale study in Ohio found measles vaccination coverage to be below the 93% herd immunity threshold, highlighting the need for sustained public health strategies to maintain elimination. The persistent immunity gaps suggest a need for equity-focused approaches.
A new study models the impact of MMR vaccination strategies on measles outbreaks in Texas, highlighting the critical role of improving immunization rates. The findings suggest that increasing vaccine coverage can significantly reduce the risk of large-scale measles outbreaks.
A recent Annenberg Public Policy Center survey found that 70% of the public supports vaccine requirements for MMR in schools. The percentage increased from 63% in August 2023. The survey also showed that over 7 in 10 U.S. adults support a policy making it mandatory for parents to vaccinate their children against preventable diseases.
The University of Texas at Arlington expert discusses the state's largest outbreak in 30 years, with fewer people getting vaccinated contributing to its spread. The MMR vaccine is 97% effective against measles and has been proven safe despite misconceptions about its safety.
A new survey finds that nearly three-quarters of US adults support requiring children to be vaccinated against preventable diseases, while over half support prohibiting unvaccinated children from attending school. However, support for this prohibition has dropped significantly since the Covid-19 pandemic, and there is growing support f...
A UK study reveals a software tool increased child vaccinations by over 1,000; healthcare professionals praise digital tool's impact on timely vaccination. The 'APL-Imms' tool uses data to identify due vaccinations and helps reduce vaccine-preventable diseases.
Scientists at WashU Medicine are developing strategies and tools to produce vaccines and antibody-based therapies for viruses from five understudied families. The effort aims to rapidly respond to potential future pandemics, with funding totaling $90M over three years.
A new study published in JAMA Network Open found live vaccinations safe and effective for children who have received liver or kidney transplants, offering protection against life-threatening conditions. The study showed high antibody levels and minimal adverse events following vaccination.
Scientists have developed a trivalent vaccine candidate that provides broad and long-lasting protection against COVID-19 infection by delivering the vaccine via the nose. The vaccine triggers a strong neutralizing antibody response and protects mucosal areas, preventing disease symptoms.
A nationwide ecological study in Brazil found a significant decline in MMR vaccine coverage between 2006 and 2020, with approximately half of municipalities falling short of the 95% target. This decline may leave these areas vulnerable to future outbreaks.
A third of under-fives attending Paediatric Emergency Departments have unmet vaccination need, with tetanus and MMR vaccination coverage levels below target. Researchers call for catch-up campaigns to reach this vulnerable group.
Researchers create a modified live attenuated mumps virus for delivery, showing it induces stronger immune responses and provides superior protection against SARS-CoV-2. The new vaccine candidate uses a prefusion version of the spike protein and offers potential to enhance MMR childhood vaccine.
Researchers have published the first-ever look at a key stage in the life cycles of measles and Nipah viruses, revealing how future therapies might stop these viruses. The study identifies how paramyxoviruses utilize a host cell lipid for viral spread, providing a new target for developing inhibitors of the assembly process.
Researchers found an inverse correlation between mumps IgG titers and COVID-19 severity in vaccinated individuals. Those with higher mumps antibody levels had lower disease severity, suggesting the MMR vaccine may be protective against COVID-19.
A study by University of California - San Francisco researchers found that over a three-year period, more than a dozen ICE detention centers experienced large, repeated outbreaks of vaccine-preventable illnesses, including influenza, chickenpox, and mumps. The Centers reported nearly half of the infections occurred in two facilities.
Administering the MMR (measles, mumps, rubella) vaccine could serve as a preventive measure to dampen septic inflammation associated with COVID-19 infection. Vaccination has no contraindications and may be especially effective for healthcare workers who can easily be exposed to COVID-19.
A recent study analyzing over 200 mumps virus genomes provides insights into the US outbreaks, revealing a dominant strain responsible for many cases. The research also demonstrates the value of high-quality genomic data in public health surveillance and suggests future efforts should incorporate whole genome sequencing.
Analyzing viral genomes from an outbreak can show how a virus is evolving and being transmitted. The study revealed new links between cases that first appeared unrelated and details about how the disease was spreading in Massachusetts and elsewhere in the US.
Outbreaks of vaccine-preventable diseases like measles and whooping cough were associated with introduction of legislation changing vaccine exemption laws in states. The study found a correlation between health improvements and increased legislative activity related to vaccine policies.
A study by Emory Vaccine Center and CDC found immunity against mumps virus insufficient in a fraction of college-aged people who received MMR as children. The results highlight the need for better understanding of immune response to mumps and vaccines.
Recent outbreaks of measles and mumps have demonstrated the importance of integrated infection prevention response. Studies show that standard patient and visitor messaging, active surveillance, and timely initiation of precautions can effectively control outbreaks. Vaccination rates were also critical in stemming the outbreak, with a ...
A recent resurgence in mumps cases in the US is attributed to declining immune protection from the mumps vaccine. Researchers propose a booster dose at age 18 as a potential solution to maintain population immunity and control outbreaks.
A new analysis from Harvard T.H. Chan School of Public Health suggests that waning immunity is a major factor in the recent mumps resurgence among young adults in the US. The study found that vaccine-derived immune protection against mumps persists for approximately 27 years after the last dose.
A study found that youth infected with HIV in utero may not have adequate immunity to measles, mumps, and rubella, even if vaccinated. Those who started antiretroviral therapy early were more likely to have protective antibodies against these diseases.
Researchers have discovered a subset of plasma cells in the bone marrow that serve as an immune archive, preserving a catalog of how the body responded to measles and mumps viruses in childhood. These long-lived cells can provide valuable insights for vaccine designers aiming to create long-lasting antibodies.
A recent mumps outbreak in Ontario, Canada highlights the importance of two doses of mumps vaccine to prevent outbreaks. Researchers found that people born between 1985 and 1991 are more susceptible to mumps, particularly among males in this age group.
Although immunity to mumps is high in the US, maintaining and improving vaccine coverage is crucial to prevent future outbreaks. The study found that only about 90% of the population has sufficient antibodies, which may not be enough to stop transmission.